| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | 155.1MM | +8% |
| Operating Income | -197.5MM | +74% |
| Operating Expenses | 352.6MM | - |
| Net Income | -320.6MM | - |
| R&D | 89.9MM | -4% |
| G&A | 37.7MM | +4% |
| Marketing | 79.1MM | +15% |
| Amortization | 600K | -14% |
| Interest Expense | 645K | +0% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
PALO ALTO, Calif., April 18, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the first quarter 2024 after market close on Thursday, May 9, 2024. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
PALO ALTO, Calif., April 03, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will present data from nine studies highlighting advances in methylation-based epigenomic analysis for precision oncology at the 2024 American Association for Cancer Research (AACR) Annual Meeting, April 5-10 in San Diego.
Exact Sciences stock surged Tuesday after the company's colon cancer-screening rival, Freenome, unveiled the results of a pivotal study.
It’s been nearly one and a half years since ChatGPT went live, but it sure doesn’t feel like it. ChatGPT has shaken up many sectors, and triggered an AI revolution. I would argue that ChatGPT is the biggest reason why the ‘Magnificent 7’ stocks have done so well. This rally, in turn, has driven the broader market higher alongside these stocks. However, this does not mean that ChatGPT is the only AI model in town. Other companies have been racing to make their own AI models. Indeed, many AI model
In this article, we will be taking a look at the 2o foods to reduce cancer risk. If you do no want learn about the global and US cancer stats, head straight to the 5 Foods To Reduce Cancer Risk. Global and US Cancer Statistics According to data from the World Cancer Research Fund International, […]
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths. It's already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
PALO ALTO, Calif., March 13, 2024--ECLIPSE study to be published in NEJM shows Shield blood-based screening test detects 83% of people with colorectal cancer.
PALO ALTO, Calif., March 06, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on February 15, 2024, the Compensation Committee of Guardant’s Board of Directors approved the granting of restricted stock units ("RSUs") representing 218,236 shares of its common stock to 82 new non-executive employees and non-qualified stock option awards to purchase an aggregate of 29,048 shares of its common stock to one new non-executive employee with a grant da
PALO ALTO, Calif., March 01, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the results of a new survey showing patients and physicians overwhelmingly agree that blood-based testing could help close the colorectal cancer (CRC) screening gap by offering a more pleasant and convenient option.
In this article, we will be taking a look at the 21 countries that have the highest rates of cancer deaths. If you do not want to learn about the global cancer care market, head straight to the 5 Countries that Have the Highest Rates of Cancer Deaths. The global impact of cancer is staggering, […]